title: Monogenic hyperinsulinemic hypoglycemia: current insights into the pathogenesis and management.
abstract: Hyperinsulinism (HI) is the leading cause of persistent hypoglycemia in children, which if unrecognized may lead to development delays and permanent neurologic damage. Prompt recognition and appropriate treatment of HI are essential to avoid these sequelae. Major advances have been made over the past two decades in understanding the molecular basis of hyperinsulinism and mutations in nine genes are currently known to cause HI. Inactivating KATP channel mutations cause the most common and severe type of HI, which occurs in both a focal and a diffuse form. Activating mutations of glutamate dehydrogenase (GDH) lead to hyperinsulinism/hyperammonemia syndrome, while activating mutations of glucokinase (GK), the "glucose sensor" of the beta cell, causes hyperinsulinism with a variable clinical phenotype. More recently identified genetic causes include mutations in the genes encoding short-chain 3-hydroxyacyl-CoA (SCHAD), uncoupling protein 2 (UCP2), hepatocyte nuclear factor 4-alpha (HNF-4α), hepatocyte nuclear factor 1-alpha (HNF-1α), and monocarboyxlate transporter 1 (MCT-1), which results in a very rare form of HI triggered by exercise. For a timely diagnosis, a critical sample and a glucagon stimulation test should be done when plasma glucose is < 50 mg/dL. A failure to respond to a trial of diazoxide, a KATP channel agonist, suggests a KATP defect, which frequently requires pancreatectomy. Surgery is palliative for children with diffuse KATPHI, but children with focal KATPHI are cured with a limited pancreatectomy. Therefore, distinguishing between diffuse and focal disease and localizing the focal lesion in the pancreas are crucial aspects of HI management. Since 2003, 18 F-DOPA PET scans have been used to differentiate diffuse and focal disease and localize focal lesions with higher sensitivity and specificity than more invasive interventional radiology techniques. Hyperinsulinism remains a challenging disorder, but recent advances in the understanding of its genetic basis and breakthroughs in management should lead to improved outcomes for these children.
authors: Division of Endocrinology and Diabetes, The Children's Hospital of Philadelphia, 3615 Civic Center Boulevard, Abramson Research Center Room 802A, Philadelphia, PA, 19104, USA. deleon@chop.edu.
authors: Katherine
authors: K
authors: Lord
authors: Diva D
authors: DD
authors: De León
references: J Clin Endocrinol Metab. 2011 Aug;96(8):2312-7
references: 21697252
references: J Pediatr Surg. 1999 May;34(5):786-92; discussion 792-3
references: 10359182
references: Nature. 1996 Dec 5;384(6608):458-60
references: 8945471
references: Rev Endocr Metab Disord. 2010 Sep;11(3):171-8
references: 20936362
references: J Clin Invest. 1997 Aug 15;100(4):802-7
references: 9259578
references: Diabetes Care. 2012 Feb;35(2):198-203
references: 22190679
references: Eur J Endocrinol. 2012 Feb;166(2):333-9
references: 22048969
references: Am J Hum Genet. 2007 Sep;81(3):467-74
references: 17701893
references: J Clin Endocrinol Metab. 2011 Dec;96(12):3785-93
references: 21956412
references: N Engl J Med. 1998 Jan 22;338(4):226-30
references: 9435328
references: J Biol Chem. 2010 Oct 8;285(41):31806-18
references: 20670938
references: N Engl J Med. 1998 May 7;338(19):1352-7
references: 9571255
references: Pediatrics. 2008 Sep;122(3):e522-8
references: 18694902
references: PLoS Med. 2007 Apr;4(4):e118
references: 17407387
references: Eur J Endocrinol. 2010 May;162(5):987-92
references: 20164212
references: Diabetes. 2011 Jun;60(6):1797-804
references: 21536946
references: J Pediatr. 1980 Feb;96(2):257-9
references: 7351590
references: Pediatr Endocrinol Rev. 2009 Mar;6(3):424-30
references: 19396028
references: Arch Dis Child. 2001 Mar;84(3):254-7
references: 11207177
references: J Nucl Med. 2005 Apr;46(4):560-6
references: 15809476
references: Diabetes. 2006 Jan;55(1):13-8
references: 16380471
references: Drug Metab Dispos. 1975 May-Jun;3(3):226-9
references: 238822
references: J Clin Invest. 2001 Aug;108(3):457-65
references: 11489939
references: Metabolism. 1964 Jun;13:487-92
references: 14193979
references: N Engl J Med. 1977 Jun 9;296(23):1323-6
references: 193007
references: Science. 2011 Oct 28;334(6055):474
references: 21979934
references: Clin Chem. 2008 Feb;54(2):256-63
references: 18156285
references: Mod Pathol. 2006 Jan;19(1):122-9
references: 16357843
references: Semin Pediatr Surg. 2011 Feb;20(1):32-7
references: 21186002
references: J Clin Endocrinol Metab. 2012 Oct;97(10):E2026-30
references: 22802087
references: Hum Mol Genet. 1996 Nov;5(11):1809-12
references: 8923010
references: J Pediatr Surg. 2011 Jan;46(1):204-8
references: 21238668
references: Mol Imaging Biol. 2013 Feb;15(1):97-105
references: 22752652
references: Diabetes. 2009 Jun;58(6):1419-27
references: 19336674
references: J Clin Invest. 2000 Oct;106(7):897-906
references: 11018078
references: Diabetes. 2008 Jun;57(6):1659-63
references: 18268044
references: Eur J Endocrinol. 2007 Oct;157(4):491-7
references: 17893264
references: PLoS One. 2008;3(12):e3850
references: 19065272
references: Diabetologia. 1984 Apr;26(4):282-9
references: 6376236
references: J Clin Endocrinol Metab. 2007 Dec;92(12):4706-11
references: 17895314
references: J Pediatr. 2006 Jul;149(1):47-52
references: 16860127
references: Diabetes. 2012 Oct;61(10):2585-91
references: 22855730
references: Dev Med Child Neurol. 2008 Dec;50(12):945-9
references: 19046187
references: J Clin Invest. 1998 Oct 1;102(7):1286-91
references: 9769320
references: Diabetes. 2003 Jan;52(1):199-204
references: 12502513
references: Pediatr Diabetes. 2010 Mar;11(2):142-7
references: 19558634
references: Science. 1995 Apr 21;268(5209):426-9
references: 7716548
references: J Clin Endocrinol Metab. 2004 Jan;89(1):288-96
references: 14715863
references: J Clin Invest. 2008 Aug;118(8):2877-86
references: 18596924
references: Horm Res. 2008;70(1):59-64
references: 18493152